Diligence memo · auto-generated · as of July 2, 2026

IllumiSonics Inc.

IllumiSonics Inc. looks over-valued against its niche peers and is dormant on financing cadence.

DeprioritizeFinancing has gone silent well past the sector's normal cadence — treat as inactive until outside confirmation of a live operation.

Businessfiled

IllumiSonics Inc. operates in Other Health Care, based in WATERLOO.

No verified homepage on file yet — operating evidence is limited to the public record.

Capital & rounds (filed)filed

IllumiSonics Inc. has raised $366K in disclosed capital across 1 recorded round, aggregated from public filings. Its latest round is modeled as Pre-Seed (a round under $1.0M).

Largest single filing: $366K on 2022-05-16.

Most recent recorded round closed around 2022-05-16.

Valuation (modeled)modeled

Provath models IllumiSonics Inc. at approximately $4.5M (range $229K–$29M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.

Read: Over-valued. Modeled value is 1.74× the median modeled value of Pre-Seed Other Health Care companies in 2022–2024 (288 peers) — value vs value, same stage and era. Issuer reports no revenue, yet is modeled well above niche peers.

Financing rhythm & timingmixed

Last raise 4.1 yr ago; this sector typically re-raises about every 14 months.

Only one round on record and long silent — often defunct, acquired, or gone quiet.

Comparablesmixed

Capital scale ranks ahead of 16% of Other Health Care peers (5377 compared).

Modeled value ranks above 19% of those peers.

Closest niche peers: Active Recovery TMS, LLC, Imagen Walled Lake Support Services, LLC, Pinnacle Integrated Medicine, Inc., Choix, Inc., DataBiologics, Inc..

Peoplefiled

6 named people on file across officers, directors and signatories.

Risks & flagsmixed

Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.

Modeled above niche peers — valuation risk on entry.

No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.